1430. Tele-Rehabilitation in Parkinson's Disease: An Update Systematic Review of the Literature

Authors: Uladzislau Ulasavets; Uladzislau Ulasavets; Fred Sarfo; Bruce Ovbiagele (Krakow, Poland)


Tele-rehabilitation provide a viable avenue to meet the rehabilitation needs of Parkinson's disease patients in developed countries as well as Low-and-Middle Income countries where Parkinson's disease burden is rapidly escalating. The aim of our study is to provide an updated systematic review of the literature on the efficacy of tele-rehabilitation interventions for recovery from motor, higher cortical dysfunction and quality of life among Parkinson's disease patients.


References for this Review were identified by searches of PubMed, Cochrane library and Google Scholar for papers published from January 1, 1980 to October 7, 2018 using the following keywords: “Telerehabilitation”, “Telerehabilitation Parkinson”, “Mobile health rehabilitation”, “Telemedicine rehabilitation”. Our inclusion criteria were randomized controlled trials, pilot or feasibility trials.


The search identified 10,035 records of which 123 were thought to be eligible based on their titles and abstracts. By consensus between two investigators, 14 publications met the criteria for inclusion and further review. Tele-rehabilitation interventions focused on motor recovery (n=6), quality of life (n=6) and higher cortical dysfunction (n=4). The duration of the intervention ranged between two weeks and 12 months with sample size in the intervention group ranging between 6 and 97. Overall, we showed that tele-rehabilitation in patients with Parkinson's disease appears to be as effective as therapies in-person for motor and higher cortical deficits as well as quality of life.  


This updated systematic review has proved that tele-rehabilitation intervention can be an effective method in rehabilitation of patients with Parkinson's disease. Larger, well-powered, longer-term studies are needed to establish the routine utility of tele-rehabilitation for Parkinson’s disease globally.